Prollenium Announces Leadership Transition
Prollenium Announces Leadership Transition Prollenium Medical Technologies (“Prollenium” or “the Company”), a leading innovator in the aesthetic medical space, has announced a significant leadership change as Ario Khoshbin, its Founder…
Sentynl Unveils First Full Clinical Data Supporting NULIBRY® for MoCD Type A
Sentynl Unveils First Full Clinical Data Supporting NULIBRY® for MoCD Type A Sentynl Therapeutics, Inc. (“Sentynl”), a U.S.-based biopharmaceutical company and a wholly owned subsidiary of Zydus Lifesciences Ltd. (“Zydus…
Prollenium Unveils New Leadership Structure
Prollenium Unveils New Leadership Structure In a significant leadership transition aimed at fostering continued growth and innovation, Prollenium Medical Technologies (“Prollenium” or “the Company”) has announced that Ario Khoshbin, the…
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company focused on the…
Hologic Appoints Wayde McMillan to Board of Directors
Hologic Appoints Wayde McMillan to Board of Directors Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment,…
Bayer Announces Petition Filing to U.S. Supreme Court for Review in Durnell Roundup Case
Bayer Announces Petition Filing to U.S. Supreme Court for Review in Durnell Roundup Case On April 4, 2025, Bayer AG, through its indirect subsidiary Monsanto, officially filed a petition for…
WHO brings countries together to test collective pandemic response
WHO brings countries together to test collective pandemic response In a significant step toward improving global pandemic preparedness, the World Health Organization (WHO) recently led a groundbreaking two-day international simulation…
FDA Issues Complete Response Letter to Aldeyra for Reproxalap Dry Eye NDA
FDA Issues Complete Response Letter to Aldeyra for Reproxalap Dry Eye NDA Aldeyra Therapeutics, Inc.a biotechnology company committed to the development of innovative therapies targeting immune-mediated and metabolic diseases, announced…
Akamis Bio Doses First Patient in Phase 1b Rectal Cancer Trial of NG-350A
Akamis Bio Doses First Patient in Phase 1b Rectal Cancer Trial of NG-350A Akamis Bio, a clinical-stage biotechnology company at the forefront of immuno-oncology innovation, announced a major milestone in…
Xaira Therapeutics Appoints Bo Wang as SVP and Head of Biomedical AI
Xaira Therapeutics Appoints Bo Wang as SVP and Head of Biomedical AI In a strategic move that underscores its deepening commitment to revolutionizing drug discovery through artificial intelligence, Xaira Therapeutics…
GoodRx Introduces New E-commerce Experience for Retail Pharmacies
GoodRx Introduces New E-commerce Experience for Retail Pharmacies GoodRx, a recognized leader in medication savings platforms across the United States, has announced the introduction of a transformative e-commerce experience designed…
The HRT Club and MyMenopauseRX Team Up to Expand Menopausal Care Access Across 21 States
The HRT Club and MyMenopauseRX Team Up to Expand Menopausal Care Access Across 21 States In a major step toward improving access to affordable and patient-centered menopause healthcare, The HRT…